e-Therapeutics plc Notice of Results (8457P)
September 05 2017 - 3:41AM
UK Regulatory
TIDMETX
RNS Number : 8457P
e-Therapeutics plc
05 September 2017
E-THERAPEUTICS PLC
("e-therapeutics" or the "Company")
Notification of Half Year Results Date
Oxford, UK - 5 September 2017 - e-therapeutics plc (AIM: ETX), a
company using Network-Driven Drug Discovery (NDD) to create new and
better drugs, will announce its half year results for the six
months ended 31 July 2017 on Tuesday, 26 September 2017.
-Ends-
For more information, please contact:
e-therapeutics plc Tel: +44 (0) 1993
Ray Barlow, Chief Executive 883 125
Officer www.etherapeutics.co.uk
Steve Medlicott, Finance
Director
Numis Securities Limited Tel: +44 (0) 207
Michael Meade/Freddie Barnfield 260 1000
(Corporate Finance) www.numis.com
James Black (Corporate
Broking)
Instinctif Partners Tel: +44 (0) 207
Melanie Toyne Sewell/Alex 457 2020
Shaw Email: e-therapeutics@instinctif.com
About e-therapeutics plc
We are an Oxford-based company with a unique and powerful
computer-based drug discovery platform and a specialised approach
to network biology.
Our novel methodology and our Discovery Engine allow us to
discover new and better drugs in a more efficient and effective
way.
e-therapeutics is headquartered in Oxford. For more information
about the Company please visit www.etherapeutics.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORVELBBDKFZBBB
(END) Dow Jones Newswires
September 05, 2017 04:41 ET (08:41 GMT)
E-therapeutics (LSE:ETX)
Historical Stock Chart
From Apr 2024 to May 2024
E-therapeutics (LSE:ETX)
Historical Stock Chart
From May 2023 to May 2024